These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 24368468)

  • 1. Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs.
    Bachhuber MA; Cunningham CO
    JAMA; 2013 Dec; 310(24):2671-2. PubMed ID: 24368468
    [No Abstract]   [Full Text] [Related]  

  • 2. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.
    Brown LS; Kritz S; Goldsmith RJ; Bini EJ; Robinson J; Alderson D; Rotrosen J
    Public Health Rep; 2007; 122(4):441-51. PubMed ID: 17639646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.
    Patel EU; Genberg BL; Zhu X; Krawczyk N; Mehta SH; Tobian AAR
    JAMA; 2022 Feb; 327(8):776-777. PubMed ID: 35191936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Provision of and Barriers to Integrating Reproductive and Sexual Health Services for Reproductive-age Women in Opioid Treatment Programs.
    Klaman SL; Lorvick J; Jones HE
    J Addict Med; 2019; 13(6):422-429. PubMed ID: 31689259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Screening of Human Immunodeficiency Virus and Other Sexually Transmitted Infections in a Group of Sex Workers in Indoor Settings in the Porto Metropolitan Area].
    Almeida N; Melo M; Soares I; Carvalho H
    Acta Med Port; 2020 Mar; 33(3):166-173. PubMed ID: 32130095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missed opportunities for hepatitis C testing in opioid treatment programs.
    Frimpong JA
    Am J Public Health; 2013 Jun; 103(6):1028-30. PubMed ID: 23597374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.
    Frimpong JA; D'Aunno T; Jiang L
    Am J Public Health; 2014 Jun; 104(6):e75-82. PubMed ID: 24825236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiting and providing less care: comprehensive services at for-profit, nonprofit, and public opioid treatment programs in the United States.
    Bachhuber MA; Southern WN; Cunningham CO
    Med Care; 2014 May; 52(5):428-34. PubMed ID: 24638120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical knowledge of human immunodeficiency virus and sexually transmitted infections among emergency medicine providers.
    Niforatos JD; Nowacki AS; Avery A; Gripshover BM; Yax JA
    Int J STD AIDS; 2019 Nov; 30(13):1290-1297. PubMed ID: 31718468
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating hepatitis, STD, and HIV services into a drug rehabilitation program.
    Gunn RA; Lee MA; Callahan DB; Gonzales P; Murray PJ; Margolis HS
    Am J Prev Med; 2005 Jul; 29(1):27-33. PubMed ID: 15958248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model to provide comprehensive testing for HIV, viral hepatitis, and sexually transmitted infections at a short-term drug treatment center.
    Lally MA; MacNevin R; Sergie Z; Hitt R; DiSpigno M; Cenedella C; Stein MD
    AIDS Patient Care STDS; 2005 May; 19(5):298-305. PubMed ID: 15916492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.
    Frimpong JA; D'Aunno T; Helleringer S; Metsch LR
    BMC Public Health; 2016 Jul; 16():666. PubMed ID: 27473519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlights From the 2019 HIV Diagnostics Conference: Optimizing Testing for HIV, STIs, and HCV.
    Chavez PR; Soehnlen MK; Van Der Pol B; Gaynor AM; Wesolowski LG; Owen SM
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S2-S7. PubMed ID: 31804298
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter From the Guest Editor.
    Van Der Pol B
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S1. PubMed ID: 32149963
    [No Abstract]   [Full Text] [Related]  

  • 16. Adoption and utilization of sexually transmitted infections testing in outpatient substance abuse treatment facilities serving high risk populations in the U.S.
    Guerrero EG; Cederbaum JA
    Int J Drug Policy; 2011 Jan; 22(1):41-8. PubMed ID: 20970314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.
    Bini EJ; Kritz S; Brown LS; Robinson J; Alderson D; Rotrosen J
    J Addict Dis; 2011 Apr; 30(2):98-109. PubMed ID: 21491291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the Hepatitis C Testing Strategy for Human Immunodeficiency Virus-Positive Men Who Have Sex With Men at the Sexually Transmitted Infections Outpatient Clinic of Amsterdam, the Netherlands.
    Jongen VW; van Rooijen MS; Schim van der Loeff MF; Newsum AM; de Vos Klootwijk L; Hoornenborg E; Hogewoning A; van der Valk M; van den Berk GEL; Prins M; Heijman T
    Sex Transm Dis; 2020 Sep; 47(9):587-595. PubMed ID: 32815900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Point-of-care testing for sexually transmitted infections: recent advances and implications for disease control.
    Tucker JD; Bien CH; Peeling RW
    Curr Opin Infect Dis; 2013 Feb; 26(1):73-9. PubMed ID: 23242343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results from a multiple morbidities testing program offering rapid HIV testing bundled with hepatitis and sexually transmitted infection testing.
    Reynolds GL; Fisher DG; Napper LE; Marsh KA; Willey C; Brooks R
    Public Health Rep; 2008; 123 Suppl 3(Suppl 3):63-9. PubMed ID: 19166090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.